Short Bowel Syndrome Market Estimated to Cross US$ 3.66 Bn by 2031

Healtcareresearch14 Jan, 2022Health

According to the report, the global short bowel syndrome market was valued at US$ 728.3 Mn in 2020 and is projected to expand at a CAGR of 15.9% from 2021 to 2031. Incentives and R&D grants for manufacturers of orphan drugs, rise in prevalence of SBS, and favorable reimbursement scenario are anticipated to propel the global short bowel syndrome market. Japan is likely to be a highly lucrative market for short bowel syndrome drugs from 2021 to 2031. The market in the country is projected to expand at a high CAGR during the forecast period.